Ronnda Bartel has over 30 years of work experience in the biopharma industry. Ronnda began their career in 1989 as the Director of Research at Advanced Tissue Sciences. Ronnda then moved to Becton Dickinson as a Senior Scientist in 1992. In 1995, they returned to Advanced Tissue Sciences as a Senior Principal Scientist. Ronnda then joined StemCells Inc. in 1998 as the Vice President of Scientific Development. In 2001, they joined SRS Capital as the Senior Director of Science and Technology. In 2004, they became the Executive Director of MicroIslet, Inc. In 2006, they joined Aastrom Biosciences as the Chief Scientific Officer and Vice President of Technical Operations. In 2018, they joined Caladrius Biosciences as the Vice President of Product Development and Manufacturing. In 2014, they founded Ronnda L Bartel Consulting LLC as a Biopharma Consultant. Most recently, in 2022, they joined Avery Therapeutics, Inc. as the Chief Technical Officer.
Ronnda Bartel earned their PhD in Biochemistry from The University of Kansas between 1980 and 1984.
October 1, 2022 - present